YPL191C Antibody

What is YPL191C and what is its function in yeast cells?

YPL191C is a gene in Saccharomyces cerevisiae that encodes a protein named Miy1 (MINDY1 in yeast). Miy1 belongs to the MINDY family of deubiquitinating enzymes (DUBs) that are involved in the regulation of protein ubiquitination . This enzyme plays a critical role in regulating the ubiquitination status of proteins at the plasma membrane, particularly by limiting the extent of polyubiquitination of membrane-associated proteins . Unlike other DUBs, Miy1 appears to function as a safeguard that protects certain membrane-associated proteins from unnecessary ubiquitination and subsequent degradation . Recombinant Miy1 has demonstrated enzymatic activity specifically toward K48-linked ubiquitin chains in vitro .

How does Miy1 regulate G protein signaling in yeast?

Miy1 interacts with Gpa1, the alpha subunit of a heterotrimeric G protein in yeast, and modulates its ubiquitination status . Research has shown that:

These findings suggest that Miy1 serves to protect Gpa1 from excessive polyubiquitination, which would otherwise target it for proteasomal degradation . By maintaining appropriate Gpa1 levels and ubiquitination states, Miy1 influences G protein-mediated pheromone responses in yeast cells.

What cellular localization pattern does Miy1 exhibit?

Miy1 exhibits a specific subcellular distribution pattern with a significant portion localized to the plasma membrane . This membrane localization is dependent on prenylation, a post-translational lipid modification . When observed using fluorescence microscopy with GFP-tagged Miy1, the protein can be visualized at the cell periphery, consistent with plasma membrane association . Biochemical fractionation experiments using sucrose gradient centrifugation can separate plasma membrane fractions (identified using markers like the heterotrimeric G protein Ste4) from cytosolic and intramembrane fractions, confirming Miy1's presence in the plasma membrane fraction .

What criteria should be considered when selecting a YPL191C/Miy1 antibody?

When selecting an antibody against YPL191C/Miy1, researchers should consider several critical factors:

• Specificity: The antibody should recognize Miy1 but not cross-react with other MINDY family members (e.g., Miy3) or unrelated proteins. This is particularly important given that Miy3 has higher expression levels than Miy1 in yeast .

• Application compatibility: Verify the antibody is validated for your specific application (Western blotting, immunoprecipitation, immunofluorescence microscopy, etc.).

• Epitope location: Consider whether the epitope is located in a conserved region of the protein. For studies involving mutant variants of Miy1, ensure the epitope is not within the mutated region.

• Controls: Ensure appropriate positive and negative controls are available. A miy1Δ strain would serve as an ideal negative control for antibody validation .

• Protocol optimization: Different fixation and permeabilization methods may be required to adequately detect membrane-associated proteins like Miy1.

Researchers studying Miy1 have successfully used immunoblotting techniques to detect both native and tagged versions of the protein in various experimental settings .

How can I validate the specificity of a YPL191C/Miy1 antibody?

To validate the specificity of a YPL191C/Miy1 antibody, implement the following methodological approach:

• Genetic controls: Compare antibody signals between wild-type yeast and miy1Δ mutant strains. A specific antibody should show signal in wild-type but not in the deletion strain .

• Tagged protein controls: Express epitope-tagged versions of Miy1 (e.g., FLAG-tagged or GFP-tagged Miy1) and confirm the antibody detects both the tagged and endogenous versions at appropriate molecular weights .

• Overexpression analysis: Compare signal intensity between strains with normal Miy1 expression and those overexpressing Miy1 from a strong promoter (e.g., GAL1 promoter) . Signal intensity should correlate with expression levels.

• Pre-absorption test: Pre-incubate the antibody with purified recombinant Miy1 protein before immunoblotting. This should abolish or significantly reduce specific signals.

• Subcellular fractionation: Verify that the antibody detects Miy1 predominantly in membrane fractions, consistent with its known localization pattern .

When validating antibodies against membrane-associated proteins like Miy1, it's important to use appropriate extraction methods that effectively solubilize membrane proteins.

What immunoprecipitation protocols work best for studying Miy1 interactions?

For successful immunoprecipitation of Miy1 and its interaction partners, the following optimized protocol has been demonstrated to be effective:

• Cell preparation: Grow yeast cells to early-log phase before harvesting by centrifugation .

• Lysis buffer composition: Use a buffer containing 50 mM NaPO₄ (pH 7.5), 400 mM NaCl, 0.1% Triton X-100, 10% glycerol, 0.5 mM DTT, with phosphatase inhibitors (25 mM NaF, 25 mM glycerophosphate, 1 mM sodium orthovanadate) and protease inhibitors (10 mM N-ethylmaleimide, 5 mM PMSF, and complete EDTA-free protease inhibitor cocktail) .

• Cell lysis method: Subject cells to glass bead vortex homogenization for 30 seconds, repeated 10 times, and centrifuge twice at 13,000 g for 10 minutes at 4°C .

• Immunoprecipitation conditions: Incubate lysates with anti-FLAG M2 affinity resin (for FLAG-tagged Miy1) for 2 hours at 4°C with gentle rotation .

• Wash conditions: Wash immunoprecipitates four times with 1 ml of lysis buffer for 3 minutes each .

• Elution method: Resuspend in 2× SDS-PAGE loading buffer for analysis by immunoblotting .

This protocol has successfully demonstrated Miy1's interaction with Gpa1, showing that Gpa1 co-immunoprecipitates with FLAG-tagged Miy1 .

How can I detect Miy1's deubiquitinating activity in cellular extracts?

To assess Miy1's deubiquitinating activity in cellular extracts, researchers can employ the Ub-AMC (ubiquitin-7-amino-4-methylcoumarin) fluorogenic substrate assay, which has been effectively used for measuring DUB activity . While this method has not been specifically reported for Miy1 in the provided references, it can be adapted based on protocols used for other DUBs:

• Sample preparation: Prepare cell lysates from wild-type and miy1Δ strains in a DUB-compatible lysis buffer (e.g., 25 mM HEPES, 5 mM EDTA, 0.1% CHAPS, 5 mM ATP) .

• Reaction setup: Incubate 100 μL of cell lysate with an equal volume of Ub-AMC substrate (500 nmol/L) at room temperature .

• Activity measurement: Monitor the release of the AMC fluorophore using a plate-reading luminometer equipped with 380 nm excitation and 440 nm emission filters .

• Controls: Include samples treated with known DUB inhibitors as negative controls and recombinant Miy1 as a positive control.

• Substrate specificity analysis: To assess Miy1's preference for K48-linked chains, compare activity using different types of ubiquitin chains (K48, K63, etc.) as substrates .

This approach can be complemented by analyzing ubiquitination patterns of known Miy1 substrates like Gpa1 through immunoblotting, comparing ubiquitination levels between wild-type and miy1Δ strains .

What methods can be used to study Miy1's membrane localization?

To investigate Miy1's membrane localization, researchers can employ a combination of biochemical fractionation and imaging techniques:

• Fluorescence microscopy with GFP-tagged Miy1:

  • Express GFP-tagged Miy1 under its native promoter

  • Grow cells to mid-log phase and concentrate before visualization

  • Place 10 μL of concentrated cell suspension on a slide with a thin 0.5% agar layer

  • Visualize using confocal microscopy to observe peripheral localization

• Subcellular fractionation via sucrose gradient:

  • Prepare whole-cell extracts from yeast

  • Separate cellular components using sucrose gradient centrifugation

  • Identify plasma membrane fractions using specific markers (e.g., heterotrimeric G protein Ste4)

  • Detect Miy1 in different fractions via immunoblotting

• Prenylation-dependent localization studies:

  • Generate mutants in the C-terminal prenylation site of Miy1

  • Compare localization of wild-type versus prenylation-deficient mutants

  • Quantify the proportion of Miy1 in membrane versus cytosolic fractions

• Protease protection assays: To determine the topology of Miy1 at the membrane, conduct protease protection assays with and without membrane permeabilization.

These approaches have successfully demonstrated that Miy1's membrane localization is dependent on prenylation, providing important insights into its biological function .

How can I differentiate between Miy1's effects on mono- versus polyubiquitination?

Distinguishing between Miy1's effects on mono- versus polyubiquitination requires a sophisticated experimental approach combining genetic manipulations with biochemical analyses:

• Genetic manipulation strategy:

  • Utilize a pep4Δ mutant strain, which enriches monoubiquitinated Gpa1

  • Compare single pep4Δ mutants with double pep4Δ miy1Δ mutants

  • Express Gpa1 in both strains and monitor both ubiquitination states

• Ubiquitination pattern analysis:

  • Immunoprecipitate the substrate of interest (e.g., Gpa1)

  • Perform immunoblotting with anti-ubiquitin antibodies

  • Analyze the pattern: monoubiquitination appears as a single additional band above the unmodified protein, while polyubiquitination appears as higher molecular weight smears

• Chain-specific antibodies:

  • Use antibodies specific for K48-linked ubiquitin chains to detect polyubiquitination

  • Compare with total ubiquitin staining to identify monoubiquitinated species

• Mass spectrometry analysis:

  • Perform tryptic digestion of purified ubiquitinated proteins

  • Identify ubiquitin attachment sites and chain linkage types via mass spectrometry

Research has demonstrated that Miy1 deletion leads to both increased polyubiquitinated Gpa1 and reduced monoubiquitinated Gpa1, suggesting that Miy1 may protect monoubiquitination status by preventing extension to polyubiquitin chains .

What approaches can resolve contradictory results when studying Miy1 function?

When encountering contradictory results in Miy1 functional studies, researchers should implement the following systematic troubleshooting approach:

• Strain background verification:

  • Confirm the genetic background of yeast strains used

  • Recreate deletion strains in multiple backgrounds to rule out strain-specific effects

  • Verify deletions by PCR and sequencing of the integration junctions

• Complementation analysis:

  • Reintroduce wild-type MIY1 under its native promoter into miy1Δ strains

  • Test if this rescues all phenotypes associated with the deletion

  • Include enzymatically inactive Miy1 mutants as controls

• Expression level considerations:

  • Compare results from endogenous expression versus overexpression systems

  • Note that overexpression may cause artifacts or mask subtle phenotypes

  • Use quantitative Western blotting to ensure comparable expression levels

• Redundancy assessment:

  • Create double mutants with other DUBs, particularly Miy3, which has higher expression

  • Test if phenotypes are enhanced in double mutants

  • Investigate potential compensatory mechanisms in single mutants

• Substrate validation:

  • Confirm direct interaction using multiple methods (co-IP, yeast two-hybrid, in vitro binding)

  • Verify substrate specificity using purified components in vitro

  • Include appropriate controls for non-specific binding

By systematically addressing these factors, researchers can resolve apparently contradictory results and develop a more complete understanding of Miy1's cellular functions.

How can quantitative proteomics be used to identify novel Miy1 substrates?

Quantitative proteomics offers powerful approaches for identifying novel Miy1 substrates beyond established targets like Gpa1:

• SILAC-based comparative proteomics:

  • Culture wild-type and miy1Δ yeast in media containing heavy or light isotope-labeled amino acids

  • Enrich for ubiquitinated proteins using tandem ubiquitin binding entities (TUBEs)

  • Compare ubiquitination profiles using mass spectrometry

  • Proteins showing increased ubiquitination in miy1Δ cells are potential substrates

• Proximity-based labeling:

  • Express Miy1 fused to a proximity labeling enzyme (BioID or TurboID)

  • Identify proteins in close proximity to Miy1 through biotinylation

  • Compare with catalytically inactive Miy1 controls to distinguish substrates from interactors

• Plasma membrane-focused analysis:

  • Isolate plasma membrane fractions from wild-type and miy1Δ strains

  • Compare ubiquitination patterns in these fractions specifically

  • Focus on membrane proteins that show altered ubiquitination

• Immunoprecipitation-mass spectrometry:

  • Immunoprecipitate Flag-tagged Miy1 with crosslinking

  • Identify co-precipitating proteins by mass spectrometry

  • Validate hits with reverse co-immunoprecipitation experiments

This methodology is supported by findings that Miy1 deletion leads to increased high molecular weight ubiquitin conjugates specifically in plasma membrane fractions, suggesting multiple membrane-associated proteins may be Miy1 substrates .

Why might Miy1 antibodies show inconsistent results in immunofluorescence microscopy?

Inconsistent immunofluorescence results with Miy1 antibodies may stem from several technical factors that require systematic troubleshooting:

• Membrane protein accessibility challenges:

  • Miy1's membrane localization may make epitopes difficult to access

  • Try multiple fixation methods (4% paraformaldehyde, methanol, or combinations)

  • Test different permeabilization approaches (0.1-0.5% Triton X-100, saponin, or digitonin)

  • For prenylated proteins like Miy1, more stringent permeabilization may be required

• Expression level considerations:

  • Endogenous Miy1 levels may be too low for detection (especially compared to Miy3)

  • Consider using GFP-FLAG-tagged Miy1 under native or inducible promoters

  • Use signal amplification methods (tyramide signal amplification or quantum dots)

• Antibody validation:

  • Verify antibody specificity using miy1Δ strains as negative controls

  • Test multiple antibodies targeting different epitopes of Miy1

  • Use epitope-tagged Miy1 and corresponding tag antibodies as positive controls

• Microscopy parameters:

  • Optimize image acquisition settings (exposure time, gain, laser power)

  • Use high-resolution microscopy techniques (confocal or super-resolution)

  • Consider deconvolution to improve signal-to-noise ratio

Best practices include using the same strain expressing GFP-FLAG-Miy1 that has been validated by Western blotting before proceeding to microscopy, and obtaining z-stack images to fully capture the plasma membrane distribution pattern .

What are the major challenges in detecting Miy1-substrate interactions?

Detecting Miy1-substrate interactions presents several technical challenges that require careful experimental design:

• Transient nature of enzyme-substrate interactions:

  • DUB-substrate interactions are often transient and difficult to capture

  • Use crosslinking agents (DSP, formaldehyde) to stabilize interactions

  • Consider substrate-trapping mutants of Miy1 that bind but don't release substrates

• Competition with other DUBs:

  • Multiple DUBs may act on the same substrates, masking Miy1-specific effects

  • Create double/triple mutants with redundant DUBs

  • Use in vitro systems with purified components to confirm direct activity

• Extraction conditions for membrane proteins:

  • Membrane-associated proteins like Miy1 require specialized extraction

  • Use optimized lysis buffers containing appropriate detergents (0.1% Triton X-100)

  • Maintain buffer conditions that preserve native protein interactions (include glycerol)

• Distinguishing direct vs. indirect effects:

  • Changes in ubiquitination could be indirect through regulatory pathways

  • Perform in vitro deubiquitination assays with purified components

  • Use proximity labeling techniques to identify proteins in close contact with Miy1

Successful detection of Miy1-Gpa1 interactions was achieved using immunoprecipitation with anti-FLAG resin for FLAG-tagged Miy1, followed by immunoblotting with anti-Gpa1 antibodies, demonstrating that optimized protocols can overcome these challenges .

How can I improve detection of ubiquitinated species in Miy1 functional studies?

Enhancing detection of ubiquitinated species is critical for assessing Miy1's deubiquitinating activity. Implement these specialized techniques:

• Sample preparation optimization:

  • Include deubiquitinase inhibitors (10 mM N-ethylmaleimide) in lysis buffers

  • Use trichloroacetic acid precipitation to preserve ubiquitin modifications

  • Process samples rapidly at cold temperatures to minimize degradation

• Enrichment strategies:

  • Use tandem ubiquitin-binding entities (TUBEs) to enrich ubiquitinated proteins

  • For specific substrates like Gpa1, immunoprecipitate the substrate first

  • Consider using ubiquitin remnant antibodies that recognize the diglycine motif left after trypsin digestion

• Detection method refinement:

  • Optimize gel separation (use gradient gels, 5-20%) for high molecular weight species

  • For Western blots, use PVDF membranes with longer transfer times for high MW proteins

  • Try various anti-ubiquitin antibodies (clone P4D1 or FK2) that recognize different epitopes

• Control experiments:

  • Include pep4Δ controls to enrich monoubiquitinated species

  • Compare with proteasome inhibitor treatment to accumulate polyubiquitinated proteins

  • Use chain-specific antibodies to differentiate K48, K63, and other linkage types

Researchers successfully detected both mono- and polyubiquitinated forms of Gpa1 by expressing Gpa1 in wild-type and miy1Δ strains, then analyzing whole-cell extracts with anti-Gpa1 antibody . The higher molecular weight forms corresponding to ubiquitinated species were clearly visible and showed increased intensity in miy1Δ mutants.